APA (7th ed.) Citation

Li, Y., Rao, M., Zhang, N., Wu, L., Lin, N., & Zhang, C. (2019). BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation. Experimental & Therapeutic Medicine, 17(6), 4547.

Chicago Style (17th ed.) Citation

Li, Yang-Ling, Ming-Jun Rao, Ning-Yu Zhang, Lin-Wen Wu, Neng-Ming Lin, and Chong Zhang. "BAY 87-2243 Sensitizes Hepatocellular Carcinoma Hep3B Cells to Histone Deacetylase Inhibitors Treatment via GSK-3β Activation." Experimental & Therapeutic Medicine 17, no. 6 (2019): 4547.

MLA (9th ed.) Citation

Li, Yang-Ling, et al. "BAY 87-2243 Sensitizes Hepatocellular Carcinoma Hep3B Cells to Histone Deacetylase Inhibitors Treatment via GSK-3β Activation." Experimental & Therapeutic Medicine, vol. 17, no. 6, 2019, p. 4547.